infect
balbc
mice
mous
hepat
viru
strain
jhm
mhvjhm
sever
interv
rel
ovalbumin
ova
administr
result
elev
ovaspecif
igg
titer
sinc
gamma
interferon
ifn
implic
upregul
igg
product
attempt
made
determin
whether
level
cytokin
modifi
sera
infect
mice
serum
ifni
detect
treatment
mhvjhminfect
mice
monoclon
antiifn
antibodi
result
high
mortal
decreas
surviv
time
enhanc
viru
titer
liver
spleen
sever
virusassoci
patholog
compar
mocktreat
infect
mice
immunotherapi
recombin
amelior
diseas
reflect
mortal
rate
viru
titer
target
organ
mice
inocul
solubl
protein
antigen
preferenti
produc
igg
igg
specif
antigen
contrast
infect
mice
sever
virus
enhanc
igg
respons
infect
viru
immun
solubl
protein
antigen
gamma
interferon
ifn
cytokin
preferenti
produc
th
subset
cd
cell
stimul
product
igg
b
lymphocyt
activ
vitro
vivo
inhibit
igg
secret
thu
postul
immun
respons
trigger
virus
mainli
activ
th
subset
helper
cell
mous
hepat
viru
mhv
singular
name
group
ofcoronavirus
famili
coronavirida
infect
laboratori
mice
worldwid
high
preval
mice
infect
mhv
exhibit
aberr
immun
respons
interfer
use
biomed
research
couteli
cowork
show
alter
proteinspecif
isotyp
respons
mice
infect
strain
mhv
one
day
prior
antigen
administr
initi
goal
current
report
experi
determin
whether
mhvjhm
infect
yield
similar
result
whether
time
viru
exposur
critic
observ
effect
report
experiment
system
alter
mhv
infect
mhvjhm
infect
balbc
mous
exploit
repres
combin
moder
virul
pantrop
viru
commonli
use
permiss
genotyp
base
observ
elev
ovalbumin
ova
specif
igg
level
sera
mice
infect
mhvjhm
sever
interv
rel
antigen
exposur
attempt
made
detect
sera
infect
mice
revers
igg
elev
administr
ifnyspecif
antibodi
effect
antibodi
immunotherapi
exogen
recombin
virusassoci
mortal
patholog
viru
replic
target
organ
examin
femal
balbcbyj
mice
jackson
laboratori
bar
harbor
five
seven
week
old
time
viru
exposur
young
adult
balbc
nunu
athym
nu
euthym
mice
obtain
life
scienc
inc
st
petersburg
fl
cr
orl
sencar
dam
litter
obtain
anim
genet
product
branch
nci
bethesda
md
randomli
select
mice
free
antibodi
common
murin
virus
arriv
mice
hous
microisol
cage
lab
product
maywood
nj
given
food
water
ad
libitum
manipul
husbandri
perform
class
ii
biolog
safeti
cabinet
infect
mice
hous
facil
separ
use
control
uninfect
mice
opencag
sentinel
mous
seromonitor
program
place
cours
report
studi
seroconvers
none
common
murin
virus
mycoplasma
pulmoni
detect
except
among
mhvinocul
immunocompet
mice
seroconvert
infect
viru
mhvjhm
american
type
cultur
collect
rockvil
md
use
form
infect
infant
mous
brain
homogen
mice
immun
ova
given
antibodi
expos
oral
infant
mous
viru
mice
treat
recombin
expos
intranas
dose
viru
intranas
exposur
balbc
mice
gener
result
nearli
mortal
wherea
mortal
rate
oral
inocul
less
unpubl
ob
group
mice
infect
per
os
mhvjhm
day
rel
intraperiton
immun
ova
tgmous
freund
complet
adjuv
fca
addit
group
uninfect
mice
receiv
ova
plu
fca
fca
mice
kill
ga
exsanguin
day
postova
fca
administr
data
three
replic
experi
pool
number
mice
per
group
shown
tabl
mice
monitor
seroconvers
evid
infect
indirect
immunofluoresc
stain
use
individu
sera
dilut
bival
antigen
consist
mhvjhm
mhv
previous
describ
result
express
geometr
mean
titer
sera
signific
valu
dilut
greater
select
sera
mice
test
igg
elimin
analysi
due
unaccept
high
background
read
ten
percent
tissu
homogen
clarifi
centrifug
supern
screen
infect
intracerebr
inocul
litter
two
day
old
sencar
mice
viru
quantifi
inocul
serial
dilut
tissu
homogen
mortal
one
week
period
record
viru
titer
calcul
method
reed
muench
monoclon
antibodi
mous
gamma
ifn
design
xmg
precipit
satur
ammonium
sulfat
extens
dialyz
pb
ph
final
product
contain
x
neutral
unit
per
ml
antibodi
test
unit
recombin
gamma
ifn
wehi
b
cell
lymphoma
bioassay
mice
given
x
neutral
unit
daili
intraperiton
rout
begin
one
day
prior
viru
exposur
one
day
prior
necropsi
recombin
mous
lot
specif
activ
x
unitsmg
puriti
accord
manufactur
obtain
amgen
biolog
thousand
oak
ca
mice
given
x
unit
intraperiton
unit
intranas
daili
day
rel
viru
exposur
liver
spleen
fix
neutral
buffer
formalin
paraffin
embed
section
tm
stain
hematoxylin
eosin
chi
squar
analysi
use
test
differ
proport
student
unpair
test
use
analyz
differ
mean
viru
titer
sera
mice
infect
mhvjhm
one
day
prior
ova
administr
contain
substanti
elev
level
antigenspecif
day
tabl
geometr
mean
titer
time
control
ova
valu
interv
suggest
delay
igg
respons
among
mice
infect
mhvjhm
three
five
day
ova
administr
sinc
sera
one
mice
test
day
contain
ovaspecif
igg
wherea
four
eleven
ovaimmun
uninfect
mice
seroconvert
interv
p
sera
higher
proport
mice
group
receiv
mhvjhm
day
rel
ova
contain
ovaspecif
day
proport
ovaimmun
uninfect
howev
differ
statist
signific
mice
infect
four
day
prior
ova
administr
ovaspecif
igg
titer
sevenfold
lower
ovaimmun
uninfect
mice
tabl
proport
igg
sera
reduc
compar
uninfect
control
sera
result
shown
number
posit
dilut
greaternumb
test
geometr
mean
enzymelink
immunosorb
assay
titer
sd
posit
sera
sera
collect
mice
day
ova
immun
yield
clearcut
pattern
igg
titer
elev
sera
mice
receiv
viru
time
seven
day
prior
ova
one
day
ova
tabl
seen
among
mice
bled
seven
day
administr
ova
mark
increas
ovaspecif
igg
increas
control
occur
among
mice
infect
one
day
prior
immun
sera
infect
mice
except
expos
viru
seven
day
prior
immun
contain
reduc
level
ovaspecif
igg
tabl
howev
greatest
reduct
mice
infect
three
day
ova
immun
threefold
mice
infect
seven
day
prior
immun
yield
igg
titer
equival
uninfect
control
isotyp
distribut
ovalbuminspecif
antibodi
also
analyz
determin
igg
ratio
sera
mice
bled
day
fig
although
two
test
may
inher
differ
sensit
paramet
would
expect
remain
rel
constant
sinc
two
assay
alway
run
parallel
reagent
use
throughout
studi
analysi
reveal
igg
level
sera
uninfect
ovaimmun
mice
higher
igg
level
contrast
ratio
less
one
sera
mice
infect
one
day
prior
immun
measur
day
elev
igg
ovaspecif
respons
group
mhvinfect
mice
preferenti
product
isotyp
mice
infect
one
day
prior
antigen
administr
suggest
mice
produc
ifni
howev
use
wehi
b
cell
lymphoma
bioassay
attempt
detect
cytokin
sera
infect
mice
fail
earlier
attempt
reason
ififni
produc
level
assay
detect
respons
induct
elev
igg
respons
treatment
ovaimmun
mhvinfect
mice
restor
least
partial
igg
ovaspecif
respons
two
experi
mice
inocul
oral
mhvjhm
treat
xmg
die
surviv
time
substanti
shorter
mocktreat
infect
mice
day
vs
day
suggest
ifni
produc
mhv
infect
influenc
cours
diseas
attempt
delin
role
ifni
pathogenesi
mhvjhm
infect
group
athym
euthym
balbc
mice
treat
monoclon
antiifni
xmg
mocktreat
dialysi
buffer
pb
expos
oral
viru
athym
mice
includ
produc
ifni
virtu
fulli
compet
natur
killer
cell
four
mice
per
genotyp
treatment
group
necropsi
daili
postinfect
day
one
five
liver
spleen
section
mice
examin
histolog
viru
organ
mice
necropsi
day
four
five
postinfect
quantifi
day
mocktreat
athym
euthym
mice
xmg
euthym
mice
rare
scatter
foci
necrot
hepat
necrosi
hepatocyt
infiltr
neutrophil
leukocyt
xmg
athym
mice
hepat
similar
qualiti
mocktreat
counterpart
necrot
foci
numer
day
differ
treatment
group
strike
xmg
athym
mice
numer
larg
coalesc
foci
hepatocellular
necrosi
modest
leukocyt
respons
fig
contrast
mocktreat
athym
mice
fewer
smaller
foci
hepat
less
necrosi
infiltr
leukocyt
fig
xmg
euthym
mice
foci
hepat
either
mocktreat
counterpart
mock
treat
athym
mice
lesion
among
latter
three
group
qualit
similar
infiltr
neutrophil
mononuclear
leukocyt
microscop
differ
treatment
group
seen
spleen
mice
necropsi
day
evid
day
xmg
athym
mice
lesser
extent
xmg
euthym
mice
sever
necrosi
periarteriolar
region
white
pulp
necrosi
present
region
spleen
mocktreat
mice
less
sever
viru
titer
liver
spleen
xmg
mice
necropsi
day
postinocul
whether
athym
euthym
higher
correspond
tissu
mocktreat
mice
tabl
athym
mice
differ
statist
signific
tissu
day
among
euthym
mice
statist
signific
differ
viru
titer
occur
spleen
liver
sinc
treatment
mhvjhminfect
balbcbyj
mice
antibodi
ifni
result
decreas
surviv
time
increas
viru
titer
two
target
tabl
viru
titer
liver
spleen
brain
treat
mice
five
day
postinocul
lower
correspond
organ
mocktreat
mice
tabl
differ
liver
titer
statist
signific
report
detail
respons
mhvinfect
mice
nonrepl
antigen
virus
mice
infect
intraperiton
two
four
day
prior
sheep
red
blood
cell
immun
yield
depress
igm
igg
plaqueform
cell
respons
wherea
mice
infect
time
one
day
red
cell
administr
yield
elev
plaqueform
cell
respons
could
correl
time
respons
rel
antigen
administr
recent
intranas
administr
mhva
one
day
prior
tetanu
toxoid
immun
result
elev
antigenspecif
igg
fourfold
decreas
percent
igg
igg
like
increas
proport
igg
result
mhvjhm
differ
immun
antigen
confirm
extend
find
show
elev
igg
ovaspecif
respons
wide
rang
infect
interv
time
crucial
howev
extent
igg
titer
exceed
igg
titer
among
mice
infect
one
day
prior
antigen
administr
mhv
infect
reportedli
increas
resist
varieti
secondari
viral
infect
preinfect
mice
mhv
increas
resist
lethal
sendai
viru
infect
normal
suscept
genotyp
interf
replic
pneumonia
viru
mice
respiratori
tract
tissu
subclin
mhv
infect
delay
increas
plasma
lactic
dehydrogenas
ldh
level
result
ldhelev
viru
natur
inappar
mhv
infect
also
increas
resist
encephalomyocard
viru
reduc
protect
effect
exogen
ifna
sinc
mhv
infect
induc
ifn
product
postul
increas
resist
secondari
infect
due
endogen
level
effect
exogen
ifn
mask
endogen
product
limit
number
report
show
modul
pathogenesi
viru
infect
treatment
mice
differ
rat
antimous
ifnf
monoclon
antibodi
sheepderiv
antibodi
recombin
result
reduc
clearanc
enhanc
replic
lymphocyt
choriomening
viru
lcmv
mice
neutral
lcmvinfect
athym
result
enhanc
viru
replic
seen
studi
report
recent
rat
antimous
monoclon
antibodi
prevent
il
recoveri
athym
mice
infect
recombin
vaccinia
viru
encod
murin
il
suggest
il
product
respons
rapid
clearanc
construct
viru
replic
associ
mortal
unaffect
among
athym
mice
infect
control
viru
construct
encod
hsv
tk
ha
howev
administr
recombin
mice
infect
control
construct
significantli
increas
surviv
time
although
treat
mice
eventu
die
dissemin
infect
resist
intraperiton
inocul
aj
mice
also
correl
abil
genotyp
produc
infect
accumul
data
strongli
suggest
whether
induc
cours
infect
administ
therapeut
limit
viral
replic
vivo
case
vaccinia
viru
encod
il
appar
mediat
recoveri
athym
mice
data
mice
expos
presum
natur
rout
mhvjhm
show
endogen
modul
pathogenesi
infect
athym
euthym
mice
earlier
studi
lcmv
current
experi
mhv
either
present
low
concentr
undetect
sera
infect
mice
despit
fact
antiifni
treatment
result
elev
viru
titer
observ
may
stem
insensit
assay
use
detect
vesicular
stomat
viru
cytopath
effect
reduct
assay
use
lcmv
studi
wehi
cell
bioassay
use
current
experi
wehi
cell
bioassay
sensit
ia
induct
assay
detect
sensit
comparison
method
report
use
sandwich
enzymelink
immunosorb
assay
report
karupiah
cowork
would
like
reveal
presenc
sera
tissu
homogen
infect
mice
base
histolog
evalu
viru
quantif
effect
administr
antibodi
mark
athym
euthym
mice
may
due
higher
endogen
concentr
euthym
mice
virtu
function
cell
well
natur
killer
cell
neither
natur
killer
cell
endogen
level
suffici
afford
protect
howev
sinc
athym
mice
die
natur
experiment
infect
mhv
mhvjhm
also
kill
virtual
balb
c
mice
expos
intranas
rout
lethal
effect
infect
could
partial
overcom
administr
recombin
concomit
signific
decreas
viru
concentr
liver
other
postul
viru
infect
preferenti
activ
ifni
produc
h
subset
cell
base
fact
infect
result
enhanc
igg
product
use
ldhelev
viru
fl
strain
mous
adenoviru
attempt
made
inhibit
virusassoci
igg
product
inject
sever
differ
ifnyspecif
monoclon
antibodi
effort
fail
although
clear
whether
treatment
simpli
affect
isotyp
distribut
whether
mice
succumb
infect
current
studi
neutral
vivo
result
high
mortal
reduc
surviv
time
therebi
inhibit
effort
show
direct
link
virusinduc
product
enhanc
igg
respons
among
mous
strain
suscept
mhv
exposur
natur
rout
lesion
mortal
occur
near
infecti
dose
level
sever
lesion
independ
viru
dose
case
mhvjhm
inocul
balbc
mous
presum
natur
rout
median
infecti
lethal
dose
essenti
ident
unpubl
data
therefor
subsequ
studi
design
reveal
whether
neutral
revers
preferenti
igg
product
requir
use
mous
genotyp
resist
lethal
effect
mhvjhm
infect
less
virul
mhv
strain
studi
mhvjhm
balbc
mous
shown
howev
endogen
ifni
modul
coronavirusassoci
mortal
viru
replic
tissu
damag
suscept
host
